The effects of ranitidine on pituitary-thyroid function

Area of Science:

• Endocrinology
• Pharmacology

Background:

• Limited research exists on ranitidine's effects on pituitary-thyroid function compared to cimetidine.
• Peptic ulcer disease patients often require medications affecting gastrointestinal and potentially endocrine systems.

Purpose of the Study:

• To investigate the impact of oral ranitidine on pituitary-thyroid function in patients with peptic ulcer disease.
• To assess ranitidine's influence on thyroid-stimulating hormone (TSH), prolactin, and thyroid hormone levels.

Main Methods:

• 10 patients with peptic ulcer disease received oral ranitidine.
• Measurements included TSH and prolactin responses to TSH-releasing hormone (TRH).
• Serum total and free thyroxine (TT4, FT4) and triiodothyronine (TT3, FT3) levels were analyzed.

Main Results:

• No significant changes were observed in TSH or prolactin responses to TRH.
• Slight, non-significant declines in TT4 and FT4 concentrations were noted.
• Slight, non-significant increases in TT3 and FT3 concentrations were observed.
• A statistically significant decline (P < 0.05) was found in the TT4/TT3 and FT4/FT3 ratios.

Conclusions:

• Ranitidine may exert a minor influence on peripheral thyroxine deiodination.
• Ranitidine has minimal effect on thyroid hormone production.
• Biochemical tests of thyroid function retain diagnostic value in patients taking ranitidine.